Glatiramer is an immunomodulator utilized for the treatment and management of multiple sclerosis. It is grouped under the following drug class(es): Peptides. Its therapeutic use is listed as multiple sclerosis agents. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2 and 6-diaminohexanoic acid. Its PubChem CID is 65370.
Glatiramer
| CAS No | 28704-27-0 |
|---|---|
| Molecular Formula | C23H41N5O11 |
| Molecular Weight | 563.6 g/mol |
| Synonyms | (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Glatiramer is an immunomodulator utilized for the treatment and management of multiple sclerosis. It is grouped under the following drug class(es): Peptides. Its therapeutic use is listed as multiple sclerosis agents.
The listed CAS number is 28704-27-0.
The listed molecular formula is C23H41N5O11.
The listed molecular weight is 563.6 g/mol.
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid.
The source lists (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2 and 6-diaminohexanoic acid.